Cargando…
Ergocalciferol in New-onset Type 1 Diabetes: A Randomized Controlled Trial
CONTEXT: The effect of the anti-inflammatory and immunomodulatory actions of vitamin D on the duration of partial clinical remission (PR) in youth with type 1 diabetes (T1D) is unclear. OBJECTIVE: This work aimed to determine the effect of adjunctive ergocalciferol on residual β-cell function (RBCF)...
Autores principales: | Nwosu, Benjamin Udoka, Parajuli, Sadichchha, Jasmin, Gabrielle, Fleshman, Jody, Sharma, Rohit B, Alonso, Laura C, Lee, Austin F, Barton, Bruce A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668202/ https://www.ncbi.nlm.nih.gov/pubmed/34913020 http://dx.doi.org/10.1210/jendso/bvab179 |
Ejemplares similares
-
FRI593 Ergocalciferol And Pancreatic β-Cell Function In New-onset Type 1 Diabetes: A Randomized Controlled Trial
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2023) -
Long-Term Growth Hormone Therapy Does Not Advance Skeletal Maturation in Children and Adolescents
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021) -
COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021) -
Prediabetes: Adherence to Nutrition Visits Decreases HbA1c in Children and Adolescents
por: Parajuli, Sadichchha, et al.
Publicado: (2022) -
Long-term GH Therapy Does Not Advance Skeletal Maturation in Children and Adolescents
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021)